Mintz Partner Lee Johnson, PhD, has been named Patent Strategy Practitioner of the Year in the 2026 LMG Life Sciences Americas Awards. The firm also received the Impact Deal of the Year – Canada award for its representation of Kye Pharmaceuticals in its licensing and distribution agreement with Neurim Pharmaceuticals for SLENYTO® in Canada.

Based in Toronto, Lee advises life sciences companies, investors, and innovators on patent strategy, portfolio development, intellectual property transactions, and commercialization matters. His practice spans a range of industries, including biotechnology, pharmaceuticals, medical devices, and emerging technologies, helping clients maximize the value of their intellectual property and support business growth.

The transaction recognized as the Impact Deal of the Year – Canada was led by Cheryl Reicin with support from Adam Falconi.

Additionally, Mintz was previously shortlisted in two firm categories, and several Mintz attorneys were recognized as finalists across multiple categories.

View the full list of 2026 LMG Life Sciences Americas Award winners here.

About Mintz
Mintz is a litigation powerhouse and business accelerator serving leaders in life sciences, private equity, energy, and technology. The world’s most innovative companies trust Mintz to provide expert advice, protect and monetize their IP, negotiate deals, source financing, and solve complex legal challenges. The firm has over 600 attorneys across offices in Boston, Los Angeles, Miami, New York, San Diego, San Francisco, Toronto, and Washington, DC.